GRASPA-AML 2012-01 study (NCT01810705): A multicenter, open, randomized phase 2b trial evaluating ERY001 (L-asparaginase encapsulated in red blood cells) plus low-dose cytarabine vs low-dose cytarabine alone, in treatment of newly diagnosed acute myeloid leukemia (AML) elderly patients, unfit for intensive chemotherapy
| Autor: | Patrice Chevallier, Xavier Thomas, Romain Guieze, Frederique Orsini, Emmanuelle Tavernier Tardy, Jean Pierre Marolleau, Ian Hitchcock, Iman El-Hariry |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Myeloid business.industry Low dose cytarabine Myeloid leukemia Intensive chemotherapy Newly diagnosed L asparaginase medicine.anatomical_structure hemic and lymphatic diseases Internal medicine Immunology medicine Hematopoietic progenitor cells business |
| Zdroj: | Journal of Clinical Oncology. 33:TPS7099-TPS7099 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | TPS7099 Background: Acute myeloid leukemia (AML) is a heterogeneous clonal disorder of hematopoietic progenitor cells and the most common malignant myeloid disorder in adults, with a median age of ... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|